Stay updated with breaking news from Jeremym levin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Ovid Therapeutics (NASDAQ:OVID – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. HC Wainwright currently has a $9.00 target price on the stock. Other analysts also recently issued reports about the stock. Wedbush began coverage on shares of Ovid Therapeutics […] ....
Brokerages Set Ovid Therapeutics Inc. (NASDAQ:OVID) PT at $8.08 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Brokerages Set Ovid Therapeutics Inc. (NASDAQ:OVID) Target Price at $8.08 defenseworld.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from defenseworld.net Daily Mail and Mail on Sunday newspapers.
Ovid Therapeutics (NASDAQ:OVID) Price Target Lowered to $3.50 at Citigroup themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ovid Therapeutics (NASDAQ:OVID) PT Lowered to $3.50 at Citigroup theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.